DOCSLIB.ORG

Overview of Symposia Tracks Overview of Symposia

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Overview of Symposia Tracks Overview of Symposia Overview of Symposia Tracks Overview of Symposia ............................................................................................................................. 1 Tracks ................................................................................................................................................... 1 1. Cell sources (autologous & allogeneic) .......................................................................................... 6 1.1. Regenerative and modelling approaches in the cardiovascular field ..................................... 6 1.2. Translating perinatal derivatives into effective therapeutics for immune-based diseases .... 6 1.3. iPSC-based bioengineering for tissue regeneration during aging and disease ....................... 6 1.4. Cell-based regenerative therapy for joint repair ..................................................................... 7 1.5. RNA Therapeutics for Bone Regeneration .............................................................................. 7 1.6. Cell-assembled tissue engineering therapies for tendon repair and regeneration ................ 7 1.7. Exogenous vs endogenous cell therapy for IVD regeneration ................................................ 8 1.8. Immune cells: alternative approach for cell-based tissue regeneration ................................ 8 1.9. Recent advances in Cell Transplantation and Angiogenesis ................................................... 8 1.10. Tissue Regeneration, Senescence and Aging ...................................................................... 9 1.11. Engineering red blood cell membranes for drug delivery ................................................... 9 2. Biomaterial design & development ............................................................................................. 10 2.1. Biomaterials and Immunomodulation .................................................................................. 10 2.2. Biomaterials for Stem Cell Culture and Differentiation for Stem Cell Therapy ..................... 10 2.3. Korea-EU combined symposium : Updates on tissue engineering approaches to treat osteoarthritis and degenerative disc disease .................................................................................... 10 2.4. Gene Delivery and Therapy in Tissue Engineering ................................................................ 11 2.5. Functionalised living materials in cell and tissue engineering .............................................. 11 2.6. Engineering extracellular matrices: Fabrication methods and applications in Regenerative Therapies ........................................................................................................................................... 11 2.7. Glycoscience in tissue engineering: from glycobiomaterials to glycosignature in regeneration ...................................................................................................................................... 12 2.8. Instructive materials for biomedical applications ................................................................. 12 2.9. Injectable Biomaterials for Translational Medicine .............................................................. 12 2.10. Bioengineering of dynamic-instructive cell microenvironments for enhanced tissue engineering applications ................................................................................................................... 13 2.11. Novel Biomaterials for the Repair of the Intervertebral Disc ............................................ 13 1 2.12. Multifunctional surfaces and biomaterial risk assessment in tissue engineering............. 13 2.13. Endogenous tissue regeneration: bioactive materials and novel technologies ................ 14 2.14. In situ tissue regeneration: endogenous cell recruitment, bioactive signals, an biomaterial design ............................................................................................................................. 14 2.15. Electroactive bioinks for biofabrication and tissue regeneration ..................................... 14 2.16. Advances in natural and bioinspired hydrogels for regenerative medicine ..................... 15 2.17. Supramolecular biomaterials ............................................................................................ 15 2.18. Smart-materials for tissue engineering under external stimulus ...................................... 15 2.19. Targeted delivery using medical devices in regenerative medicine ................................. 16 2.20. What about the bacteria? ................................................................................................. 16 2.21. 20 years in silk technologies from production, clinical translation, to commercialization 16 2.22. Bio-inspired technologies for Peripheral Nerve Repair ..................................................... 17 3. Biofabrication................................................................................................................................ 18 3.1. Disruptive biofabrication techniques, materials and strategies for application in TE&RM .. 18 3.2. Melt Electrowriting ................................................................................................................ 18 3.3. Smart biomaterials and dynamic biofabrication processes powered by light ...................... 18 3.4. Microfluidic Biofabrication: a hybrid platform for the printing of functional hierarchical tissues 19 3.5. Scaffold-free strategy for tissue engineering ........................................................................ 19 3.6. Clinical applications of the Kenzan method .......................................................................... 19 3.7. Bioprinting and bioassembly as means for automated realization of 3D tissue constructs . 19 3.8. Biofabrication of (multiscale) vasculature and vascularized organs and tissues .................. 20 3.9. Osteochondral defects: engineering the cell-matrix interface with additive manufacturing. The AO Collaborative Research Program. ......................................................................................... 20 3.10. Image-based High-resolution Biofabriation ...................................................................... 21 3.11. Biofabrication and Stem Cell Research in Space ............................................................... 21 3.12. Embedded Approaches for Advanced Biofabrication ....................................................... 21 3.13. Medical electrospinning: art of science? ........................................................................... 22 3.14. When biofabrication meets bioreactors: implementing construct maturation and functional tissue culture .................................................................................................................... 22 3.15. Sound patterns as a novel biofabrication platform........................................................... 23 3.16. Toward a model-based control of biohybrid implant maturation - MoReBioMed / DFG PAK 961 patterns as a novel biofabrication platform ....................................................................... 23 2 4. Mechanisms of action ................................................................................................................... 24 4.1. Developmentally inspired therapies for joint diseases and large bone defects ................... 24 4.2. Immunomodulation to enhance bone healing ...................................................................... 24 4.3. To Scaffold or not to Scaffold? Strategies for the realization of biomimetic neuronal microenvironments ........................................................................................................................... 24 4.4. Harnessing the Extracellular Matrix for driving tissue repair ................................................ 25 4.5. Harnessing the host response for materials-driven in situ tissue regeneration ................... 25 4.6. Biomimetic elastin-generating approaches to restoring functional elastic tissues .............. 26 4.7. Advanced therapies for cardiac regeneration ....................................................................... 26 4.8. Towards effective vascularisation and angiogenesis of tissue engineered grafts ................ 27 4.9. Engineering functional in vitro microenvironments to control cell fate ............................... 27 4.10. Lung and airway engineering ............................................................................................ 27 4.11. Tissue Engineering innovations in Otology ....................................................................... 28 4.12. Mechanobiology for 3D soft materials .............................................................................. 28 4.13. Extracellular Vesicles for Tissue Regeneration: Integrated perspectives from Industry, Academia and Clinic .......................................................................................................................... 28 4.14. Informing Stem Cell-Based Tissue Engineering with lessons from embryonic development 29 4.15. Respiratory, Reproductive, Urologic and Gastrointestinal Tissue Engineering - Different Organs, Similar Strategies? ................................................................................................................ 29 5. Process engineering .....................................................................................................................
Load more

Recommended publications
  • Theory and Practice of Lineage Tracing
    REGENERATIVE MEDICINE Theory and Practice of Lineage Tracing a,b YA-CHIEH HSU Key Words. Cell surface markers • Stem cell-microenvironment interactions • Cell cycle • Cell biology • Adult stem cells aDepartment of Stem Cell ABSTRACT and Regenerative Biology, Lineage tracing is a method that delineates all progeny produced by a single cell or a group of Harvard University, cells. The possibility of performing lineage tracing initiated the field of Developmental Biology Cambridge, Massachusetts, and continues to revolutionize Stem Cell Biology. Here, I introduce the principles behind a suc- USA; bHarvard Stem Cell cessful lineage-tracing experiment. In addition, I summarize and compare different methods for Institute, Cambridge, conducting lineage tracing and provide examples of how these strategies can be implemented Massachusetts, USA to answer fundamental questions in development and regeneration. The advantages and limita- Correspondence: Ya-Chieh Hsu, tions of each method are also discussed. STEM CELLS 2015;33:3197–3204 Department of Stem Cell and Regenerative Biology, Harvard University, 7 Divinity Ave., SIGNIFICANCE STATEMENT Cambridge, Massachusetts 02138, USA. Telephone: Lineage relationships allow one to understand the cellular hierarchy of a tissue or organ, which (617) 496-3757; Fax: (617) 496- is central to both Developmental Biology and Stem Cell Biology. Different approaches have 3763; e-mail: yachiehhsu@fas. been developed to conduct lineage tracing. Understanding the underlying basis of these harvard.edu approaches, as well as their advantages and limitations, will allow one to choose the most Received March 26, 2015; appropriate method for a given question. accepted for publication June 23, 2015; first published online STEM CELLS in EXPRESS August 3, cells that are marked at the initial time point, 2015.
    [Show full text]
  • Do Humans Possess the Capability to Regenerate?
    The Science Journal of the Lander College of Arts and Sciences Volume 12 Number 2 Spring 2019 - 2019 Do Humans Possess the Capability to Regenerate? Chasha Wuensch Touro College Follow this and additional works at: https://touroscholar.touro.edu/sjlcas Part of the Biology Commons, and the Pharmacology, Toxicology and Environmental Health Commons Recommended Citation Wuensch, C. (2019). Do Humans Possess the Capability to Regenerate?. The Science Journal of the Lander College of Arts and Sciences, 12(2). Retrieved from https://touroscholar.touro.edu/sjlcas/vol12/ iss2/2 This Article is brought to you for free and open access by the Lander College of Arts and Sciences at Touro Scholar. It has been accepted for inclusion in The Science Journal of the Lander College of Arts and Sciences by an authorized editor of Touro Scholar. For more information, please contact [email protected]. Do Humans Possess the Capability to Regenerate? Chasha Wuensch A Chasha Wuensch graduated in May 2018 with a Bachelor of Science degree in Biology and will be attending pharmacy school. Abstract Urodele amphibians, including newts and salamanders, are amongst the most commonly studied research models for regenera- tion .The ability to regenerate, however, is not limited to amphibians, and the regenerative process has been observed in mammals as well .This paper discusses methods by which amphibians and mammals regenerate to lend insights into human regenerative mechanisms and regenerative potential .A focus is placed on the urodele and murine digit tip models,
    [Show full text]
  • Repair, Regeneration, and Fibrosis Gregory C
    91731_ch03 12/8/06 7:33 PM Page 71 3 Repair, Regeneration, and Fibrosis Gregory C. Sephel Stephen C. Woodward The Basic Processes of Healing Regeneration Migration of Cells Stem cells Extracellular Matrix Cell Proliferation Remodeling Conditions That Modify Repair Cell Proliferation Local Factors Repair Repair Patterns Repair and Regeneration Suboptimal Wound Repair Wound Healing bservations regarding the repair of wounds (i.e., wound architecture are unaltered. Thus, wounds that do not heal may re- healing) date to physicians in ancient Egypt and battle flect excess proteinase activity, decreased matrix accumulation, Osurgeons in classic Greece. The liver’s ability to regenerate or altered matrix assembly. Conversely, fibrosis and scarring forms the basis of the Greek myth involving Prometheus. The may result from reduced proteinase activity or increased matrix clotting of blood to prevent exsanguination was recognized as accumulation. Whereas the formation of new collagen during the first necessary event in wound healing. At the time of the repair is required for increased strength of the healing site, American Civil War, the development of “laudable pus” in chronic fibrosis is a major component of diseases that involve wounds was thought to be necessary, and its emergence was not chronic injury. appreciated as a symptom of infection but considered a positive sign in the healing process. Later studies of wound infection led The Basic Processes of Healing to the discovery that inflammatory cells are primary actors in the repair process. Although scurvy (see Chapter 8) was described in Many of the basic cellular and molecular mechanisms necessary the 16th century by the British navy, it was not until the 20th for wound healing are found in other processes involving dynamic century that vitamin C (ascorbic acid) was found to be necessary tissue changes, such as development and tumor growth.
    [Show full text]
  • Wound Healing: a Paradigm for Regeneration
    SYMPOSIUM ON REGENERATIVE MEDICINE Wound Healing: A Paradigm for Regeneration Victor W. Wong, MD; Geoffrey C. Gurtner, MD; and Michael T. Longaker, MD, MBA From the Hagey Laboratory for Pediatric Regenerative Medi- CME Activity cine, Department of Surgery, Stanford University, Stanford, Target Audience: The target audience for Mayo Clinic Proceedings is primar- relationships with any commercial interest related to the subject matter ily internal medicine physicians and other clinicians who wish to advance of the educational activity. Safeguards against commercial bias have been CA. their current knowledge of clinical medicine and who wish to stay abreast put in place. Faculty also will disclose any off-label and/or investigational of advances in medical research. use of pharmaceuticals or instruments discussed in their presentation. Statement of Need: General internists and primary care physicians must Disclosure of this information will be published in course materials so maintain an extensive knowledge base on a wide variety of topics covering that those participants in the activity may formulate their own judgments all body systems as well as common and uncommon disorders. Mayo Clinic regarding the presentation. Proceedings aims to leverage the expertise of its authors to help physicians In their editorial and administrative roles, William L. Lanier, Jr, MD, Terry L. understand best practices in diagnosis and management of conditions Jopke, Kimberly D. Sankey, and Nicki M. Smith, MPA, have control of the encountered in the clinical setting. content of this program but have no relevant financial relationship(s) with Accreditation: College of Medicine, Mayo Clinic is accredited by the Accred- industry. itation Council for Continuing Medical Education to provide continuing med- The authors report no competing interests.
    [Show full text]
  • Live Imaging and Computational Modelling of Tissue Growth and Tissue Regeneration in Drosophila
    Live Imaging and Computational Modelling of Tissue Growth and Tissue Regeneration in Drosophila Jamie Rickman 19th January 2015 Abstract Wound healing in the epithelium of the Drosophila wing imaginal disc is a regenerative process which is known to proceed via the assembly of a contractile actin cable that circumscribes the wound drawing the leading edge cells together in a characterstic rosette formation. Here we computation- ally explore various other biological and mechanical processes that are involved in tissue repair in Drosophila; the formation of dynamic actin protrusions that pull each other forward to close the wound; the active extrusion of dead cells from the wound site; and the effect of a global tension force operating on the tissue. In silico simulation results, using the vertex model of epithelial tissue, and in vivo data are compared. It is found that patterning of line tensions in wounded cells and cells neighbouring the wound can drive rosette formation and wound closure. Results from simulating a global tension force indicate this could recapitulate the initial expansion phase of wound healing seen in experiment. Contents 1 Introduction 2 1.1 Tissue regeneration . 2 1.2 Regenerative healing in Drosophila wing imaginal discs . 2 1.3 The mechanical drivers of epithelial wound healing in Drosophila . 3 2 The Vertex Model 4 3 Current work and results 5 3.1 Wound closure in vivo ...................................... 5 3.1.1 Wound closure rate . 5 3.1.2 Rosette formation . 5 3.1.3 Inital expansion of wound following ablation . 6 3.2 Wound Closure in silico ..................................... 7 3.2.1 Implementation of the vertex model .
    [Show full text]
  • Artificial Organ Introduction an Artificial Organ Is a Man-Made
    Artificial Organ Introduction An artificial organ is a man-made device that is implanted or integrated into a human body to replace a natural organ or restoring a specific function so the patient may return to as normal a life as possible. They can be used both for functions that are essential to life and also for purposes that are not related to survival but do improve a person's quality of life. The organs that can be replaced artificially are quite numerous (including the ears, ovaries, and even the heart and brain), eg. artificial heart, pacemaker, artificial kidney machine, heart-lung machine, etc. Perhaps the most common manifestation of an artificial organ is hearing aids that are used to improve a person's ability to hear and distinguish sounds. The replaced function doesn't necessarily have to be related to life support, but the ultimate goal of artificial organ research and development is fully functional created organs that can be integrated into the body which fully replaces the natural organ and remains functional for a lifetime. Many steps have been taken towards this goal, and it is very likely that the field will continue to change and develop. The reasons to construct and install an artificial organ might include: Life support to prevent imminent death while awaiting a transplant (e.g. artificial heart) Dramatic improvement of the patient's ability for self care (e.g. artificial limb) Improvement of the patient's ability to interact socially (e.g. cochlear implant) Cosmetic restoration after cancer surgery or accident Previously, an artificial organ would be created completely out of synthetic material, such as plastics or metals.
    [Show full text]
  • Serotonin Signaling Regulates Insulin-Like Peptides for Growth, Reproduction, and Metabolism in the Disease Vector Aedes Aegypti
    Serotonin signaling regulates insulin-like peptides for growth, reproduction, and metabolism in the disease vector Aedes aegypti Lin Linga,b and Alexander S. Raikhela,b,1 aDepartment of Entomology, University of California, Riverside, CA 92521; and bInstitute for Integrative Genome Biology, University of California, Riverside, CA 92521 Contributed by Alexander S. Raikhel, September 6, 2018 (sent for review May 15, 2018; reviewed by Christen Mirth, Michael R. Strand, and Marc Tatar) Disease-transmitting female mosquitoes require a vertebrate individuals have completed adequate growth to enter the next de- blood meal to produce their eggs. An obligatory hematophagous velopmental stage (5, 6). Although other DILPs promote growth, lifestyle, rapid reproduction, and existence of a large number of their specific expression patterns suggest that they might carry out transmittable diseases make mosquitoes the world’s deadliest an- distinct physiological functions (2). In Drosophila larvae, dilps1,-2, imals. Attaining optimal body size and nutritional status is critical -3,and-5 are expressed predominantly in neurosecretory cells for mosquitoes to become reproductively competent and effective (IPCs, insulin producing cells) of the brain; ablation of larval IPCs disease vectors. We report that blood feeding boosts serotonin reduces body size with delayed metamorphosis (7). These DILPs concentration and elevates the serotonin receptor Aa5HT2B regulate growth by means of the canonical insulin/insulin-like (Aedes aegypti 5-hydroxytryptamine receptor, type 2B) transcript growth factor (IGF) pathway. Single gene mutations in insulin/ level in the fat-body, an insect analog of the vertebrate liver and IGF components have been shown to cause a reduction in growth adipose tissue.
    [Show full text]
  • Delta-Notch Signaling: the Long and the Short of a Neuron’S Influence on Progenitor Fates
    Journal of Developmental Biology Review Delta-Notch Signaling: The Long and the Short of a Neuron’s Influence on Progenitor Fates Rachel Moore 1,* and Paula Alexandre 2,* 1 Centre for Developmental Neurobiology, King’s College London, London SE1 1UL, UK 2 Developmental Biology and Cancer, University College London Great Ormond Street Institute of Child Health, London WC1N 1EH, UK * Correspondence: [email protected] (R.M.); [email protected] (P.A.) Received: 18 February 2020; Accepted: 24 March 2020; Published: 26 March 2020 Abstract: Maintenance of the neural progenitor pool during embryonic development is essential to promote growth of the central nervous system (CNS). The CNS is initially formed by tightly compacted proliferative neuroepithelial cells that later acquire radial glial characteristics and continue to divide at the ventricular (apical) and pial (basal) surface of the neuroepithelium to generate neurons. While neural progenitors such as neuroepithelial cells and apical radial glia form strong connections with their neighbours at the apical and basal surfaces of the neuroepithelium, neurons usually form the mantle layer at the basal surface. This review will discuss the existing evidence that supports a role for neurons, from early stages of differentiation, in promoting progenitor cell fates in the vertebrates CNS, maintaining tissue homeostasis and regulating spatiotemporal patterning of neuronal differentiation through Delta-Notch signalling. Keywords: neuron; neurogenesis; neuronal apical detachment; asymmetric division; notch; delta; long and short range lateral inhibition 1. Introduction During the development of the central nervous system (CNS), neurons derive from neural progenitors and the Delta-Notch signaling pathway plays a major role in these cell fate decisions [1–4].
    [Show full text]
  • Molecular Cell and Developmental Biology Graduate Program 2018-2019
    Molecular Cell and Developmental Biology Graduate Program 2018-2019 The Ph.D. track in Molecular Cell and Developmental Biology (MCD) is designed to prepare students for productive careers in biological research and teaching. This training program emphasizes applying diverse approaches, including biochemistry, genetics, genomics, and imaging, to addressing critical questions in molecular, cellular, and developmental biology. Interdisciplinary research is encouraged and supported by a diverse group of faculty from the Departments of Molecular Cell & Developmental Biology (MCD), Chemistry & Biochemistry (Chem), Microbiology & Environmental Toxicology (METX), Biomolecular Engineering (BME), the Santa Cruz Institute for Particle Physics (Physics), and Ecology & Evolutionary Biology (EEB). MCD Faculty James Ackman Visualizing structured activity throughout the developing vertebrate brain Manny Ares Mechanisms and regulation of splicing machinery; structure and function of small RNAs Joshua Arribere Analyzing RNA quality control in C. elegans Needhi Bhalla Meiotic chromosome dynamics Hinrich Boeger Chromatin structure and gene regulation Barry Bowman Membrane biochemistry, genetics, and molecular biology Susan Carpenter Long non-coding RNAs in innate immunity Bin Chen Molecular control of neuronal identity and connectivity in mammalian brains David Feldheim Topographic mapping in vertebrates/CNS Grant Hartzog Chromatin and transcription Lindsay Hinck Molecular basis of neuronal chemotropism Melissa Jurica Structural approaches to large macromolecular
    [Show full text]
  • Particular Reference to the Development of Theneural
    The role of embryology in teratological research, with particular reference to the development of the neural tube and heart M. H. Kaufman Department ofAnatomy, University of Cambridge, Cambridge CB2 3DY, U.K. Introduction There are many intriguing questions that the experimental embryologist can attempt to answer which could provide insight into the pathogenesis of many of the commoner types of congenital abnormalities that affect the human population. I should like to draw attention to certain areas of embryological interest, and make some general and personal observations on teratological research. I shall concentrate on two particular areas of interest, namely studies into the pathogenesis of neural tube closure defects and cardiovascular anomalies because these are the topics of my special interests. Two quite different, but complementary approaches may be employed in experimental teratological research to investigate how certain agents act on specific organs or tissues of the embryo or fetus to induce their abnormal development. The first approach takes cognizance of the nature and chemical structure of the agent under investigation, in order to determine at the biochemical level what the underlying mechanism and principal sites of action are likely to be. The primary effect of the agent may be to disrupt maternal metabolism, and the effect on the embryo or fetus may be secondary to the effect on the mother. In these latter circumstances it is not uncommon for an embryotoxic effect to be produced before any toxic manifestation becomes apparent in the mother. The second approach takes cognizance of the morphological abnormalities which may be induced by embryonic exposure to a teratogenic agent, in order to determine in the first instance at which stage of gestation the teratogenic insult is likely to have occurred, and, also, its site of action at the cellular and tissue level.
    [Show full text]
  • A Socioethical View of Bioprinting Human Organs and Tissues Niki Vermeulen,1 Gill Haddow,1 Tirion Seymour,1 Alan Faulkner-Jones,2 Wenmiao Shu2
    Global medical ethics J Med Ethics: first published as 10.1136/medethics-2015-103347 on 20 March 2017. Downloaded from PAPER 3D bioprint me: a socioethical view of bioprinting human organs and tissues Niki Vermeulen,1 Gill Haddow,1 Tirion Seymour,1 Alan Faulkner-Jones,2 Wenmiao Shu2 ► Additional material is ABSTRACT induced pluripotent stem cells (iPSCs)) to print 3D published online only. To view In this article, we review the extant social science and constructs composed of living organic materials. please visit the journal online (http:// dx. doi. org/ 10. 1136/ ethical literature on three-dimensional (3D) bioprinting. These new forms of printing, should they be rea- medethics- 2015- 103347). 3D bioprinting has the potential to be a ‘game-changer’, lised, will, it is argued, have the same revolutionary printing human organs on demand, no longer and democratising effect as book printing in their 1Department of Science, necessitating the need for living or deceased human applicability to regenerative medicine and industry. Technology and Innovation donation or animal transplantation. Although the Individually designed biological structures or body Studies, University of Edinburgh, Edinburgh, UK technology is not yet at the level required to bioprint an parts will become as available as text in modern lit- 2Department of Biomedical entire organ, 3D bioprinting may have a variety of other erate societies. Engineering, University of mid-term and short-term benefits that also have positive There are obvious links drawn between 21st Strathclyde, Glasgow, UK ethical consequences, for example, creating alternatives century 3D bioprinting and the development of the to animal testing, filling a therapeutic need for minors 15th century printing press in terms of process as Correspondence to and avoiding species boundary crossing.
    [Show full text]
  • Cell Fate and Cell Morphogenesis in Higher Plants
    Cell fate and cell morphogenesis in higher plants John W Schiefelbein University of Michigan, Ann Arbor, USA The differentiation of plant cells depends on the regulation of cell fate and cell morphogenesis. Recent studies have led to the identification of mutants and the cloning of genes that influence these processes. In several instances, the genes encode products with homeodomains or Myb or Myc DNA-binding domains. Current Opinion in Genetics and Development 1994, 4:647451 Introduction mutants led eo the early notion that iUVl influences the Gte of leaf cells. Recent studies have shed light on the In higher plants, the formation and differentiation of normaI role of KNY. In localization experiments, KNl cells occurs in an orderly manner, ofien near meristems, is undetectable in leaves, but it is abundant in the api- which are groups of dividing cells chat act like permanent cal meristem and the immature axes of vegetative and stem cell populations. Cell differentiation in plants dif- floral shoots [7]. Also, the dominant Knl-N2 mutation fers horn that in animals because, for the most part, of a has been found to cause ectopic expression, such that lack of the relative cell movements that are characteristic KZVZ transcripts and KNl protein are detected in lateral of animal development. Also, the rigid plant cell wall veins of developing leaves (in addition to the normal makes the control of cell shape a critical aspect of cell accumulation in the meristem), which correlates well differentiation in plants. with the alterations in leaf cell fite and knot forma- The fate of undifferentiated plant cells is influenced pri- tion associated with Krzl mutants [7].
    [Show full text]